Healthcare Services

Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

The cell therapy processing market covered in this report is segmented –

1) By Offering Type: Products, Services, Software

2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

Read the full cell therapy processing market report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

Cell Line Development Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

Cell Cultures Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cell Expansion Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795